Drug Discovery & Pharmaceuticals

RSS

Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other Angel investors.

From Kuano Ltd. 13 Sep 2023

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.

11 Sep 2023

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

Vibrant green leaves sprout from tall fragrant plants sitting neatly in two rows of terracotta pots in Valerie Sponsel's UTSA biology laboratory.

8 Sep 2023

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.

6 Sep 2023

Waters Corporation and Princeton University announce multi-year research collaboration

Waters Corporation announced a multi-year research collaboration with Princeton University that will enable scientists, faculty, and students to work together to bring their diverse skills and backgrounds to solve complex challenges in biochemistry and materials science.

From Waters Corporation 24 Aug 2023

Griffith on the brink of technological breakthrough in vaccine development

Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.

23 Aug 2023

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class drug to treat cardiovascular disease (CVD) as a significant improvement to current treatment regimens -; specifically for adverse events arising from atherosclerosis.

22 Aug 2023

New powerful antibiotic isolated from bacteria could combat multi-resistant 'superbugs'

A new powerful antibiotic, isolated from bacteria that could not be studied before, seems capable to combat harmful bacteria and even multi-resistant 'superbugs'.

22 Aug 2023

Natural bioactive molecules can relieve cold and flu symptoms

Researchers at Applied Biological Laboratories Inc. discovered how natural bioactive molecules can effectively relieve cold and flu symptoms by protecting the mucosal barrier function and reducing inflammation during these infections.

16 Aug 2023

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

The history of using human challenge trials in developing vaccines.

15 Aug 2023

Unveiling α1-AR secrets: breakthrough structures and targeted drug design

Researchers explored the structural basis of agonist specificity of α1A-adrenergic receptors (α1-ARs).

14 Aug 2023

Researchers design one-step procedure for improving effective of adoptive cell immunotherapy against solid tumors

Researchers developed a one-step method to engineer multifunctional M1 phenotype macrophages.

14 Aug 2023

Duke researchers develop potent antibiotic against drug-resistant superbugs

A scientific journey decades in the making at Duke University has found a new antibiotic strategy to defeat gram-negative bacteria like Salmonella, Pseudomonas and E. coli, the culprits in many urinary tract infections (UTIs).

9 Aug 2023

New antibody shows promise in reversing carfentanil overdoses

An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.

7 Aug 2023

Researchers discover novel breakthrough treatment for fungal infections

Researchers with the University of Oklahoma’s Natural Products Discovery Group recently published findings that indicate a novel breakthrough treatment for fungal infections.

7 Aug 2023

Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service

Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, today announced it has received notification from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) that the Company is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme, and is, therefore, able to offer GLP compliant hERG ion channel screening services to the global life sciences community.

From Metrion Biosciences Limited 7 Aug 2023

New PCNA inhibitor AOH1996 shows selective cancer cell killings and tumor suppression potential

Study described a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) that selectively kills cancer cells.

4 Aug 2023

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.

2 Aug 2023

Added sugar consumption linked to greater risk of kidney stones

Between 7% and 15% of people in North America, between 5% and 9% of people in Europe, and between 1% and 5% of people in Asia suffer from kidney stones.

2 Aug 2023

New treatment offers hope for children suffering from rare skin condition

It’s a beautiful moniker, but for Australia’s ‘butterfly children’ it belies a devastating reality filled with enormous pain and suffering caused by a rare skin condition – Epidermolysis Bullosa (EB).

2 Aug 2023

Drug Discovery & Pharmaceuticals

Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

Waters Corporation and Princeton University announce multi-year research collaboration

Griffith on the brink of technological breakthrough in vaccine development

Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease

New powerful antibiotic isolated from bacteria could combat multi-resistant 'superbugs'

Natural bioactive molecules can relieve cold and flu symptoms

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

Unveiling α1-AR secrets: breakthrough structures and targeted drug design

Researchers design one-step procedure for improving effective of adoptive cell immunotherapy against solid tumors

Duke researchers develop potent antibiotic against drug-resistant superbugs

New antibody shows promise in reversing carfentanil overdoses

Researchers discover novel breakthrough treatment for fungal infections

Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service

New PCNA inhibitor AOH1996 shows selective cancer cell killings and tumor suppression potential

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Added sugar consumption linked to greater risk of kidney stones

New treatment offers hope for children suffering from rare skin condition

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News